Sars-CoV-2 in pregnancy: Why is it better than expected?
- PMID: 32739606
- PMCID: PMC7378463
- DOI: 10.1016/j.ejogrb.2020.07.025
Sars-CoV-2 in pregnancy: Why is it better than expected?
Abstract
Since the outbreak of Coronavirus disease in December 2019, information specific to pregnancy remains limited and controversial. Based on data from previous reports, it has been noticed that contrary to prior pandemics such as SARS, MERS and H1N1 and although pregnancy is usually considered as a condition of high susceptibility to viral infections, new SARS-CoV2 infection seems to have a more benign clinical course when affecting pregnant women. We speculate that during pregnancy the physiological "silencing" of the Th1 pro-inflammatory response may blunt the cytokines storm which is thought to play a key-role in the pathogenesis of the severe complications of Covid-19.
Keywords: Immunology; Inflammation; Pregnancy; Sars-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None to declare
Figures
References
-
- Dashraath P., Jing Lin Jeslyn W., Mei Xian Karen L., Li Min Lim, Li S., Biswas A., et al. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy [published online ahead of print, 2020 Mar 23] Am J Obstet Gynecol. 2020;S0002-9378(20):30343–30344. doi: 10.1016/j.ajog.2020.03.021. - DOI
-
- Maleki Dana P., Kolahdooz F., Sadoughi F., Moazzami B., Chaichian S., Asemi Z. COVID-19 and pregnancy: a review of current knowledge. Infez Med. 2020;28(suppl 1):46–51. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
